Review



human osm duoset elisa kit  (R&D Systems)


Bioz Verified Symbol R&D Systems is a verified supplier
Bioz Manufacturer Symbol R&D Systems manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 94

    Structured Review

    R&D Systems human osm duoset elisa kit
    Human Osm Duoset Elisa Kit, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 25 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/hosm+elisa/Human+Oncostatin+M+(OSM)+DuoSet+ELISA/pm41963923-110-14-21
    Average 94 stars, based on 25 article reviews
    human osm duoset elisa kit - by Bioz Stars, 2026-09
    94/100 stars

    Images

    Related Articles

    Enzyme-linked Immunosorbent Assay:

    Article Title: OSM potentiates preintravasation events, increases CTC counts, and promotes breast cancer metastasis to the lung
    Article Snippet: .. The serum was then diluted 1:3 in PBS and used in an hOSM ELISA (catalogue number DY295; R&D Systems, Minneapolis MN, USA), which was performed in accordance with the manufacturer’s instructions. ..



    Similar Products

    94
    R&D Systems human osm duoset elisa kit
    Human Osm Duoset Elisa Kit, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/hosm+elisa/Human+Oncostatin+M+(OSM)+DuoSet+ELISA/pm41963923-110-14-21
    Average 94 stars, based on 1 article reviews
    human osm duoset elisa kit - by Bioz Stars, 2026-09
    94/100 stars
      Buy from Supplier

    94
    R&D Systems gk e0008h human osm elisa kit r
    Gk E0008h Human Osm Elisa Kit R, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/hosm+elisa/Human+Oncostatin+M+(OSM)+DuoSet+ELISA/pmc11967757__ADVS___12___2413682___s001-92-179-184
    Average 94 stars, based on 1 article reviews
    gk e0008h human osm elisa kit r - by Bioz Stars, 2026-09
    94/100 stars
      Buy from Supplier

    92
    Elabscience Biotechnology immunoassay kit
    Immunoassay Kit, supplied by Elabscience Biotechnology, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/hosm+elisa/Human+OSM+(Oncostatin+M)+ELISA+Kit/pmc10886802-58-10-13
    Average 92 stars, based on 1 article reviews
    immunoassay kit - by Bioz Stars, 2026-09
    92/100 stars
      Buy from Supplier

    93
    R&D Systems human osm
    Human Osm, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/hosm+elisa/Human+Oncostatin+M+(OSM)+DuoSet+ELISA/pm37476931-18-15-17
    Average 93 stars, based on 1 article reviews
    human osm - by Bioz Stars, 2026-09
    93/100 stars
      Buy from Supplier

    94
    R&D Systems human osm duoset elisa development kit
    MBM-derived leukemia inhibitory factor (LIF) upregulates JunB expression in microglia via JAK/STAT3 signaling. ( A ) Western blot analysis of JunB and β-tubulin in microglia cells treated with MCM combined with STAT3 (S727) inhibitor (zoledronic acid), JAK inhibitor (baricitinib), JNK inhibitor (SP600125), MEK/ERK inhibitor (U0126), and DMSO as a control for 3 h. Representative blot and quantification of JunB expression are presented (normalized to cells treated with MCM + DMSO). Data are shown as mean expression + SEM of biological replicates. * p < 0.05, ** p < 0.01, *** p < 0.005. ( B ) Western blot analysis of JunB and β-tubulin expression in microglia cells treated with LIF (25 ng/mL), <t>OSM</t> (50 ng/mL), IL-4 (20 ng/mL), IL-6 (20 ng/mL), IL-15 (50 ng/mL), and IL-27 (20 ng/mL) for 3 h. Representative blot and quantification of JunB expression are presented. Data are shown as mean expression + SEM of biological replicates. * p < 0.05. ( C ) <t>ELISA</t> measurement of LIF in MCM. The bars represent the average cytokine concentration + SEM. ( D ) Western blot analysis of p-STAT3 (Tyr705) and STAT3 expression in microglia cells treated with LIF (25 ng/mL) for 10 min. Representative blot and quantification of p-STAT3 (Tyr705), STAT3, and β-tubulin expression are presented. Data are shown as mean expression + SEM of biological replicates. * p < 0.05. ( E ) Western blot analysis of JunB and β-tubulin expression in microglia cells treated with LIF (25 ng/mL) with or without baricitinib for 3 h. Representative blot and quantification of JunB expression are presented. Data are shown as mean expression + SEM of biological replicates. * p < 0.05. ( F ) Flow cytometry analysis of LIFR and gp130 expression in microglia cells. ( G , 1–4) Western blot analysis of JunB and β-tubulin in microglia cells treated with or without MCM with LIFR inhibitor (EC359) or DMSO as control for 3 h. Representative blot and quantification of JunB expression are presented. Data are shown as mean expression + SEM of biological replicates. * p < 0.05, ** p < 0.01. In all the experiments, unless indicated otherwise, microglia cells grown in starvation medium served as controls.
    Human Osm Duoset Elisa Development Kit, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/hosm+elisa/Human+Oncostatin+M+(OSM)+DuoSet+ELISA/pmc10605008-83-46-53
    Average 94 stars, based on 1 article reviews
    human osm duoset elisa development kit - by Bioz Stars, 2026-09
    94/100 stars
      Buy from Supplier

    91
    OriGene immunosorbent assay elisa kit by origene
    MBM-derived leukemia inhibitory factor (LIF) upregulates JunB expression in microglia via JAK/STAT3 signaling. ( A ) Western blot analysis of JunB and β-tubulin in microglia cells treated with MCM combined with STAT3 (S727) inhibitor (zoledronic acid), JAK inhibitor (baricitinib), JNK inhibitor (SP600125), MEK/ERK inhibitor (U0126), and DMSO as a control for 3 h. Representative blot and quantification of JunB expression are presented (normalized to cells treated with MCM + DMSO). Data are shown as mean expression + SEM of biological replicates. * p < 0.05, ** p < 0.01, *** p < 0.005. ( B ) Western blot analysis of JunB and β-tubulin expression in microglia cells treated with LIF (25 ng/mL), <t>OSM</t> (50 ng/mL), IL-4 (20 ng/mL), IL-6 (20 ng/mL), IL-15 (50 ng/mL), and IL-27 (20 ng/mL) for 3 h. Representative blot and quantification of JunB expression are presented. Data are shown as mean expression + SEM of biological replicates. * p < 0.05. ( C ) <t>ELISA</t> measurement of LIF in MCM. The bars represent the average cytokine concentration + SEM. ( D ) Western blot analysis of p-STAT3 (Tyr705) and STAT3 expression in microglia cells treated with LIF (25 ng/mL) for 10 min. Representative blot and quantification of p-STAT3 (Tyr705), STAT3, and β-tubulin expression are presented. Data are shown as mean expression + SEM of biological replicates. * p < 0.05. ( E ) Western blot analysis of JunB and β-tubulin expression in microglia cells treated with LIF (25 ng/mL) with or without baricitinib for 3 h. Representative blot and quantification of JunB expression are presented. Data are shown as mean expression + SEM of biological replicates. * p < 0.05. ( F ) Flow cytometry analysis of LIFR and gp130 expression in microglia cells. ( G , 1–4) Western blot analysis of JunB and β-tubulin in microglia cells treated with or without MCM with LIFR inhibitor (EC359) or DMSO as control for 3 h. Representative blot and quantification of JunB expression are presented. Data are shown as mean expression + SEM of biological replicates. * p < 0.05, ** p < 0.01. In all the experiments, unless indicated otherwise, microglia cells grown in starvation medium served as controls.
    Immunosorbent Assay Elisa Kit By Origene, supplied by OriGene, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/hosm+elisa/Human+OSM-R+ELISA+Kit/pm37373282-129-12-17
    Average 91 stars, based on 1 article reviews
    immunosorbent assay elisa kit by origene - by Bioz Stars, 2026-09
    91/100 stars
      Buy from Supplier

    94
    R&D Systems human osm duo set elisa kit
    MBM-derived leukemia inhibitory factor (LIF) upregulates JunB expression in microglia via JAK/STAT3 signaling. ( A ) Western blot analysis of JunB and β-tubulin in microglia cells treated with MCM combined with STAT3 (S727) inhibitor (zoledronic acid), JAK inhibitor (baricitinib), JNK inhibitor (SP600125), MEK/ERK inhibitor (U0126), and DMSO as a control for 3 h. Representative blot and quantification of JunB expression are presented (normalized to cells treated with MCM + DMSO). Data are shown as mean expression + SEM of biological replicates. * p < 0.05, ** p < 0.01, *** p < 0.005. ( B ) Western blot analysis of JunB and β-tubulin expression in microglia cells treated with LIF (25 ng/mL), <t>OSM</t> (50 ng/mL), IL-4 (20 ng/mL), IL-6 (20 ng/mL), IL-15 (50 ng/mL), and IL-27 (20 ng/mL) for 3 h. Representative blot and quantification of JunB expression are presented. Data are shown as mean expression + SEM of biological replicates. * p < 0.05. ( C ) <t>ELISA</t> measurement of LIF in MCM. The bars represent the average cytokine concentration + SEM. ( D ) Western blot analysis of p-STAT3 (Tyr705) and STAT3 expression in microglia cells treated with LIF (25 ng/mL) for 10 min. Representative blot and quantification of p-STAT3 (Tyr705), STAT3, and β-tubulin expression are presented. Data are shown as mean expression + SEM of biological replicates. * p < 0.05. ( E ) Western blot analysis of JunB and β-tubulin expression in microglia cells treated with LIF (25 ng/mL) with or without baricitinib for 3 h. Representative blot and quantification of JunB expression are presented. Data are shown as mean expression + SEM of biological replicates. * p < 0.05. ( F ) Flow cytometry analysis of LIFR and gp130 expression in microglia cells. ( G , 1–4) Western blot analysis of JunB and β-tubulin in microglia cells treated with or without MCM with LIFR inhibitor (EC359) or DMSO as control for 3 h. Representative blot and quantification of JunB expression are presented. Data are shown as mean expression + SEM of biological replicates. * p < 0.05, ** p < 0.01. In all the experiments, unless indicated otherwise, microglia cells grown in starvation medium served as controls.
    Human Osm Duo Set Elisa Kit, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/hosm+elisa/Human+Oncostatin+M+(OSM)+DuoSet+ELISA/pm35278823-88-11-18
    Average 94 stars, based on 1 article reviews
    human osm duo set elisa kit - by Bioz Stars, 2026-09
    94/100 stars
      Buy from Supplier

    Image Search Results


    MBM-derived leukemia inhibitory factor (LIF) upregulates JunB expression in microglia via JAK/STAT3 signaling. ( A ) Western blot analysis of JunB and β-tubulin in microglia cells treated with MCM combined with STAT3 (S727) inhibitor (zoledronic acid), JAK inhibitor (baricitinib), JNK inhibitor (SP600125), MEK/ERK inhibitor (U0126), and DMSO as a control for 3 h. Representative blot and quantification of JunB expression are presented (normalized to cells treated with MCM + DMSO). Data are shown as mean expression + SEM of biological replicates. * p < 0.05, ** p < 0.01, *** p < 0.005. ( B ) Western blot analysis of JunB and β-tubulin expression in microglia cells treated with LIF (25 ng/mL), OSM (50 ng/mL), IL-4 (20 ng/mL), IL-6 (20 ng/mL), IL-15 (50 ng/mL), and IL-27 (20 ng/mL) for 3 h. Representative blot and quantification of JunB expression are presented. Data are shown as mean expression + SEM of biological replicates. * p < 0.05. ( C ) ELISA measurement of LIF in MCM. The bars represent the average cytokine concentration + SEM. ( D ) Western blot analysis of p-STAT3 (Tyr705) and STAT3 expression in microglia cells treated with LIF (25 ng/mL) for 10 min. Representative blot and quantification of p-STAT3 (Tyr705), STAT3, and β-tubulin expression are presented. Data are shown as mean expression + SEM of biological replicates. * p < 0.05. ( E ) Western blot analysis of JunB and β-tubulin expression in microglia cells treated with LIF (25 ng/mL) with or without baricitinib for 3 h. Representative blot and quantification of JunB expression are presented. Data are shown as mean expression + SEM of biological replicates. * p < 0.05. ( F ) Flow cytometry analysis of LIFR and gp130 expression in microglia cells. ( G , 1–4) Western blot analysis of JunB and β-tubulin in microglia cells treated with or without MCM with LIFR inhibitor (EC359) or DMSO as control for 3 h. Representative blot and quantification of JunB expression are presented. Data are shown as mean expression + SEM of biological replicates. * p < 0.05, ** p < 0.01. In all the experiments, unless indicated otherwise, microglia cells grown in starvation medium served as controls.

    Journal: Cancers

    Article Title: Heterogeneity in the Metastatic Microenvironment: JunB-Expressing Microglia Cells as Potential Drivers of Melanoma Brain Metastasis Progression

    doi: 10.3390/cancers15204979

    Figure Lengend Snippet: MBM-derived leukemia inhibitory factor (LIF) upregulates JunB expression in microglia via JAK/STAT3 signaling. ( A ) Western blot analysis of JunB and β-tubulin in microglia cells treated with MCM combined with STAT3 (S727) inhibitor (zoledronic acid), JAK inhibitor (baricitinib), JNK inhibitor (SP600125), MEK/ERK inhibitor (U0126), and DMSO as a control for 3 h. Representative blot and quantification of JunB expression are presented (normalized to cells treated with MCM + DMSO). Data are shown as mean expression + SEM of biological replicates. * p < 0.05, ** p < 0.01, *** p < 0.005. ( B ) Western blot analysis of JunB and β-tubulin expression in microglia cells treated with LIF (25 ng/mL), OSM (50 ng/mL), IL-4 (20 ng/mL), IL-6 (20 ng/mL), IL-15 (50 ng/mL), and IL-27 (20 ng/mL) for 3 h. Representative blot and quantification of JunB expression are presented. Data are shown as mean expression + SEM of biological replicates. * p < 0.05. ( C ) ELISA measurement of LIF in MCM. The bars represent the average cytokine concentration + SEM. ( D ) Western blot analysis of p-STAT3 (Tyr705) and STAT3 expression in microglia cells treated with LIF (25 ng/mL) for 10 min. Representative blot and quantification of p-STAT3 (Tyr705), STAT3, and β-tubulin expression are presented. Data are shown as mean expression + SEM of biological replicates. * p < 0.05. ( E ) Western blot analysis of JunB and β-tubulin expression in microglia cells treated with LIF (25 ng/mL) with or without baricitinib for 3 h. Representative blot and quantification of JunB expression are presented. Data are shown as mean expression + SEM of biological replicates. * p < 0.05. ( F ) Flow cytometry analysis of LIFR and gp130 expression in microglia cells. ( G , 1–4) Western blot analysis of JunB and β-tubulin in microglia cells treated with or without MCM with LIFR inhibitor (EC359) or DMSO as control for 3 h. Representative blot and quantification of JunB expression are presented. Data are shown as mean expression + SEM of biological replicates. * p < 0.05, ** p < 0.01. In all the experiments, unless indicated otherwise, microglia cells grown in starvation medium served as controls.

    Article Snippet: For the estimation of intracellular OSM levels, MBM cells were plated and grown in starvation media for 72 h. The cells were then lysed as previously described [ ], and 2 μg of the lysates was used to determine the intracellular levels of OSM using the Human OSM DuoSet ELISA Development Kit (DY295, R&D Systems).

    Techniques: Derivative Assay, Expressing, Western Blot, Control, Enzyme-linked Immunosorbent Assay, Concentration Assay, Flow Cytometry